Pregnancy and Childbirth
Conditions
Interventions
administration of im tramadol to parturients in active phase of labour
injection Im pentazocine
Sponsors
Self
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Pregnant women in labour at 37–42weeks gestation admitted at cervical dilatation of 4–5 cm, who consented to participate in the study.
Exclusion criteria
Exclusion criteria: Parturients, with: 1. Known allergy to tramadol or pentazocine. 2. Contraindication to vaginal delivery eg.malpresentation, 3. Pregnancy complicated by fetal distress, and intrauterine fetal death. 4. Maternal medical conditions such as cardiopulmonary depression, HIV, TB 5. Antepartum haemorrhage 6. History of recent/chronic liver disease and renal disease 7. Those with prior analgesic administration. 8. Multiple gestation and complications 9. Spinal cord injuries, 10. BMI ?18 and ?30 11. Cervical dilatation =6cmand =3cm
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is to determine and compare the number of participants with adequate pain relief when either of tramadol or pentazocine is administered for labour analgesia using the visual analogue scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes will be the incidence of maternal side effects like; dizziness, weakness, nausea, vomiting; participants satisfaction with analgesic regimen and baby’s APGAR score in the 1st and 5th minutes respectively | — |
Countries
Nigeria
Contacts
Public ContactJohannes Odidika Umeora
Professor Department of Obstetrics and Gynaecology AEFUTHA
Outcome results
None listed